Major population health real-world studies such as SCoMIS, which examines the use of Wegovy in the Scottish population will read-out by 2029, and SURMOUNT-REAL will provide definitive insights into whether use of Obesity Medicines brings healthcare system benefits in the form of, for example, reduced cardiovascular events, diabetes or disability, and may also provide data on wider socio-economic benefits, such as reduced unemployment
From a more general point of view, it is particularly interesting that these drugs exert their therapeutic action by acting on the brain to reduce appetite and thus create a significant caloric deficit
This medication works by slowing the stomach's emptying process and signaling to the brain that you feel full sooner, naturally reducing food intake and controlling appetite
Notably, only two-thirds of tirzepatide patients reached doses of 10 mg, 12.5 mg, or 15 mg in the current real-world study
In rare cases, severe low blood sugar can be life threatening
doi: 10.23937/2378-3656/1410281 97 DesaiAPetrovJHashashJGPatelHBrahmbhattBKochharGSet al
